✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Anuh Pharma Ltd.

ANUHPHR

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹840 Cr.
P/E
18.21

Anuh Pharma Ltd.

  • Anuh Pharma
  • Bharat Parenterals
  • Ind-Swift Lab.
  • TJI Pharma - Small Cap

FAQs on Anuh Pharma Ltd. Shareprice

Anuh Pharma has given lower returns compared to its competitors.
Anuh Pharma has grown at ~9.51% over the last 4yrs while peers have grown at a median rate of 22.15%

Anuh Pharma is not expensive.
Latest PE of Anuh Pharma is 18.01, while 3 year average PE is 19.27.
Also latest EV/EBITDA of Anuh Pharma is 13.55 while 3yr average is 13.64.

View FAQ's On Business

Growth Table

  • Anuh Pharma Ltd.
  • Bharat Parenterals
  • Ind-Swift Lab.

Balance Sheet

  • Anuh Pharma Ltd.
  • Bharat Parenterals
  • Ind-Swift Lab.

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Anuh Pharma Ltd.
  • Bharat Parenterals
  • Ind-Swift Lab.

Cash Flow

  • Anuh Pharma Ltd.
  • Bharat Parenterals
  • Ind-Swift Lab.

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Anuh Pharma Ltd.
  • Bharat Parenterals
  • Ind-Swift Lab.

Quarterly Results

  • Anuh Pharma Ltd.
  • Bharat Parenterals
  • Ind-Swift Lab.

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Anuh Pharma Ltd. Financials

Balance sheet of Anuh Pharma is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Anuh Pharma is decreasing.
Latest net debt of Anuh Pharma is -₹28.96 Crs as of Mar-25.
This is less than Mar-24 when it was -₹14.72 Crs.

No, profit is decreasing.
The profit of Anuh Pharma is ₹46.14 Crs for TTM, ₹47.35 Crs for Mar 2025 and ₹60.06 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Anuh Pharma latest dividend payout ratio is 15.87% and 3yr average dividend payout ratio is 21.48%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech